Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study.
BACKGROUND: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents new HIV infections. The optimal scenario for implementing PrEP where most infections are averted at the lowest cost is unknown. We determined the impact of different PrEP strategies on averting new infe...
Main Authors: | Brooke E Nichols, Charles A B Boucher, Janneke H van Dijk, Phil E Thuma, Jan L Nouwen, Rob Baltussen, Janneke van de Wijgert, Peter M A Sloot, David A M C van de Vijver |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3601101?pdf=render |
Similar Items
-
Cost effectiveness of PrEP in Europe
by: Brooke Nichols
Published: (2018-05-01) -
Understanding pre-exposure prophylaxis (PrEP) regimen use: Switching and discontinuing daily and event-driven PrEP among men who have sex with men
by: Liza Coyer, et al.
Published: (2020-12-01) -
HIV pre-exposure prophylaxis (PrEP): strategy with future?
by: Francisco Miguel da Costa Grilo
Published: (2019) -
Initial implementation of PrEP in Zambia: health policy development and service delivery scale-up
by: Cheryl Hendrickson, et al.
Published: (2021-07-01) -
Home-based pre-exposure prophylaxis (PrEP) services for gay and bisexual men: An opportunity to address barriers to PrEP uptake and persistence.
by: Steven A John, et al.
Published: (2017-01-01)